BLISS GVS PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112.6 INR | -0.71% |
|
+11.11% | -9.67% |
| 06-20 | Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable | MT |
| 05-02 | Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
